Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Nektar Therapeutics
NKTR
$2.39B
| $466K | ﹤0.01% |
23,886
+11,706
| +96% | +$223K |
|
3727
Riley Exploration Permian
REPX
$744M
| $466K | ﹤0.01% |
17,574
+10,997
| +167% | +$303K |
|
3728
CALL
Insulet
PODD
$11.5B
| $466K | ﹤0.01% |
2,000
-2,100
| -51% | -$431K |
|
|
EB
3729
DELISTED
Eventbrite
EB
| $463K | ﹤0.01% |
169,642
+102,283
| +152% | +$389K |
|
3730
Vivid Seats
SEAT
$84.6M
| $463K | ﹤0.01% |
6,258
+4,877
| +353% | +$444K |
|
3731
Invesco DB Agriculture Fund
DBA
$1.23B
| $463K | ﹤0.01% |
17,747
| – | – |
|
3732
Mineralys Therapeutics
MLYS
$2.25B
| $463K | ﹤0.01% |
38,218
+28,208
| +282% | +$341K |
|
|
SKX
3733
PUT
DELISTED
Skechers
SKX
| $462K | ﹤0.01% |
+6,900
| New | +$453K |
|
|
LGTY
3734
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $461K | ﹤0.01% |
41,180
+30,291
| +278% | +$315K |
|
3735
Treace Medical Concepts
TMCI
$280M
| $460K | ﹤0.01% |
79,696
+62,073
| +352% | +$399K |
|
3736
Farmers & Merchants Bancorp
FMAO
$459M
| $459K | ﹤0.01% |
16,610
+12,375
| +292% | +$318K |
|
|
SWN
3737
DELISTED
Southwestern Energy Company
SWN
| $459K | ﹤0.01% |
64,515
-270,501
| -81% | -$1.75M |
|
3738
Graham Corp
GHM
$1.12B
| $459K | ﹤0.01% |
15,498
+4,145
| +37% | +$124K |
|
3739
Gencor Industries
GENC
$209M
| $458K | ﹤0.01% |
21,957
+9,938
| +83% | +$200K |
|
3740
Hyliion Holdings
HYLN
$635M
| $458K | ﹤0.01% |
184,685
+135,055
| +272% | +$272K |
|
|
USAP
3741
DELISTED
Universal Stainless & Alloy
USAP
| $454K | ﹤0.01% |
11,761
+2,023
| +21% | +$72.1K |
|
3742
Lexeo Therapeutics
LXEO
$324M
| $454K | ﹤0.01% |
50,210
+31,057
| +162% | +$370K |
|
3743
Klaviyo
KVYO
$5.34B
| $454K | ﹤0.01% |
12,825
+11,840
| +1,202% | +$343K |
|
3744
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.44B
| $453K | ﹤0.01% |
18,632
| – | – |
|
3745
Banco Santander Chile
BSAC
$16.3B
| $453K | ﹤0.01% |
21,800
-14,100
| -39% | -$283K |
|
|
IBDQ
3746
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $451K | ﹤0.01% |
17,975
| – | – |
|
3747
Seneca Foods Class A
SENEA
$1.12B
| $450K | ﹤0.01% |
7,222
+5,466
| +311% | +$331K |
|
|
TRUE
3748
DELISTED
TrueCar
TRUE
| $449K | ﹤0.01% |
130,062
+81,745
| +169% | +$262K |
|
3749
DocGo
DCGO
$64.3M
| $448K | ﹤0.01% |
134,923
+99,387
| +280% | +$338K |
|
3750
Savers
SVV
$1.58B
| $447K | ﹤0.01% |
42,501
-46,706
| -52% | -$476K |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.